Table 4 Outcomes from hospital admission, stratified by pre-existing hypertension

From: The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19

  

Pre-existing hypertension

 

Characteristic

Overall, N = 9197

No, N = 4754 (51.7%)

Yes, N = 4443 (48.3%)

p value

In-hospital mortality

2020 (22.0%)

867 (18.2%)

1153 (26.0%)

<0.001

Discharged alive

6498 (70.7%)

3524 (74.1%)

2974 (66.9%)

<0.001

Discharged alive- Palliative

68 (0.7%)

37 (0.8%)

31 (0.7%)

0.7

Transfer to other facility

611 (6.6%)

326 (6.9%)

285 (6.4%)

0.4

Length of stay in hospital, days

8 (4, 16)

8 (4, 16)

9 (5, 17)

<0.001

Admission to ICU

1908 (20.7%)

1,081 (22.7%)

827 (18.6%)

<0.001

Length of stay ICU, days

12 (6, 22)

12 (6, 23)

12 (6, 22)

>0.9

Non-invasive ventilation

986 (10.7%)

559 (11.8%)

427 (9.6%)

<0.001

Invasive ventilation

1568 (17.0%)

887 (18.7%)

681 (15.3%)

<0.001

  1. p value is for comparison between pre-existing hypertension and no pre-existing hypertension documented, using Wilcoxon rank sum test or Chi-squared test
  2. ICU intensive care unit